Patients: In total, 162 of 223 OLT recipients (median age 51 yrs, 75% men)who had available BMD and spinal radiographs but who were not receiving bone-modifying treatment at screening for OLT were included in the study.
above or below that of an age-and sex matched reference population). World Health Organization (WHO) criteria were used to define osteoporosis: T-score of -2,5 or less and osteopenia: a T-score between -1 SD and -2.5 SD.
Due consideration was given to the need to adjust mean BMD scores of the LS in the presence of one or more lumbar vertebral fractures at the site of the LS BMD measurement (L1-L4).
Vertebral fracture assessment
Conventional anterior-posterior and lateral radiographs of the thoracic spine and postero-anterior and lateral radiographs of the lumbar spine were performed by an experienced radiology technician using a standardized protocol, at a distance of 115 cm, with the film centralized on Th7 for the thoracic spine and on L3 for the lumbar spine.
All radiographs were blindly assessed for the presence and severity (grade) of vertebral fractures by two independent observers, an experienced musculoskeletal radiologist (H.K.) and an experienced bone and mineral disorders specialist ( N.H.).
Fractures were assessed using the Genant's semi-quantitative method of vertebral fracture assessment. (17) Using this method, a decrease in height of 20-25% is considered to be a "mild" grade 1 fracture, a decrease of 25-40% a "moderate" grade 2 fracture and a decrease of > 40% a "severe" grade 3 fracture. Uniform loss of vertebral height compared to adjacent vertebrae were additionally documented using the same grading scores. Radiographs were assessed in a random order, using random numbers generated by SPSS software (version 20) . A unique number was assigned to each series of radiographs performed at screening for OLT. Radiographs were individually scored by the two independent observers and in case of discrepancy in scores, mostly about fracture grading, consensus was achieved by both observers reviewing the radiographs together. Careful attention was given to the interpretation of vertebral deformities, excluding vertebral height reductions or deformities due to development abnormalities, degenerative changes, osteochondritis, (Scheuermann's disease) or localised metabolic bone disorders such as Paget's disease of bone. We chose to calculate odds ratios rather than risk ratios because of the regression models used. A p-value < 0.05 was considered significant.
We evaluated the direct effect of various risk factors, such as cholestatic or alcoholic liver disease, on the outcome parameter, such as prevalence of fractures, as well as the indirect effect of the risk factor on the outcome of through various mediators, such as vitamin D deficiency, using a logistic regression model. We calculated confidence intervals of the effect of mediators using the bootstrap method.
Calculations were performed using STATA/SE 12.0 software (StataCorp LP, TX, USA).
results

Patients characteristics
In total, 162 of the 201 patients, who received an elective OLT in the 10-year period between 2000 and 2011, who had available BMD measurements and conventional spinal radiographs performed at the time of screening before liver transplantation but who
were not treated with bisphosphonates, corticosteroids or other bone-modifying agents were included in the study. Of the 39 excluded patients, 21 had for logistics reasons no Median age for women was also 51 years (range 16 -66), and 23 women were younger than 50 years. Menopausal status was not documented. Most common liver pathology was viral or alcoholic liver disease (31 and 29% respectively), followed by cholestatic liver disease (14%). 8% of patients were using calcium and vitamin D supplements, usually as a combination preparation at a fixed dose of 500mg calcium and 400 IU cholecalciferol, which had been initiated at some stage before screening for transplantation. Details of patients' characteristics are shown in Table 1 .
biochemical data
Mean serum creatinine concentration was 89 ± 47 µmol/L (normal < 104 µmol/L).
Median bilirubin level was 32 µmol/L (range 4-1172, normal < 17 µmol/L). Mean INR was were also low, with a mean of 31 ± 24 nmol/L in patients using vitamin D supplements.
Of the 162 patients studied 110 patients had 25-OHD levels < 50 nmol/L, of whom 54 patients had levels of < 25 nmol/L. Mean laboratory MELD-score, reflecting severity of liver disease, was 14 ± 6 SD (range 6-35).
bmd measurements
Osteoporosis and osteopenia were prevalent in respectively 19 and 38 % of patients at the LS, and in 11 and 42% of patients at the FN. Mean T-score was -1.15 ± 1.44 at the LS and -1.06 ± 1.23 at the FN. Mean Z-score was -0.63 ± 1.49 at the LS and -0.15 ± 1.21 at the FN.
Distribution of BMD at the LS and FN are shown for men and women in Figure 2 .
factors associated with a low bmd
We evaluated a number of potential risk factors for low BMD at time of screening for transplantation (Table 2 ). Age and gender were not associated with increased risk for osteoporosis. Cholestatic liver disease was associated with significant increased risk for osteoporosis at the FN in the univariate model (OR 1.23, 95% CI 1.07-1.41, p = 0.004), but 
Prevalence of radiographic vertebral fractures
We documented 186 vertebral fractures in 90 patients, representing a prevalence of 56%. 43 patients (44%) had one prevalent fracture, 25 had two fractures (15%), and 22
had three or more fractures (14%). Over 50% of patients had one or more mild grade 1 fracture (52%), of whom eleven patients (10%) also had moderate grade 2 fractures.
None of the patients studied had severe grade 3 vertebral fractures. The anatomical distribution of the fractures is shown in Figure 3 ; 47 patients had lumbar vertebral lumbar vertebrae. The majority of these fractures were single grade 1 fractures, with no significant impact on total LS BMD, so that they were not excluded from the analysis of total BMD.
Mid-thoracic compression fractures, usually involving 2-3 vertebrae, most commonly thoracic vertebrae 7 to 9, were prevalent in 7 patients (6%).
factors associated with radiographic vertebral fractures
We found no significant relationship between BMD and prevalent vertebral fractures using either univariate or multivariate analysis. In patients with prevalent fractures, 38%
had a normal BMD, 40 % had osteopenia and only 23% had osteoporosis. There was no significant association between BMD as a continuous variable, the presence or absence of low BMD, and the presence or absence of vertebral fractures, number of fractures per individual patient or grade of severity of the fractures.
Male gender was associated with a higher prevalence of vertebral fractures than female gender, with an odds ratio of 4.10 (95% CI 1.73-9.67, p = 0.001), independently of age, underlying disease pathology or severity of liver disease as expressed by the laboratory MELD score (Table 3) . Age as a continuous parameter, vitamin D status, underlying liver disease and severity of liver disease were not associated with an increased prevalence of vertebral fractures. by the prerequisite alcohol abstinence for at least six months prior to screening for The high prevalence of vertebral fractures of 56% observed in our cohort at time of screening before transplantation is much higher than the overall prevalence of fractures of 7% observed in a recent Dutch population-based cohort of men and women aged > 55 years, in which all subjects were screened by conventional spinal X-rays. (23) The observed prevalence of vertebral fractures in our study was also higher than that of previously published studies, which showed a widely variable and overall lower prevalence of these fractures (3 to 36%), in patients awaiting liver A limitation of our study is its retrospective study design. However, the laboratory, radiological and densitometric investigations were not randomly undertaken, but formed an integral part of a pre-planned pre-transplantation screening protocol for skeletal complications, performed in patients with end-stage liver failure, who in this case went on to receive a liver transplantation. Although most candidates for liver transplantation were screened for skeletal complications, we only studied those who subsequently received a liver transplant, which may have led to an underestimate of the true prevalence of skeletal pathology, since the excluded patients would have been more likely to have had the more severe liver disease and thus potentially the more severe skeletal complications. We also chose to exclude patients using corticosteroids and /or bisphosphonates, which could have also led to the exclusion of patients with the worst skeletal pathology. However, since this was the case in a relatively small number of patients, this is unlikely to have affected the outcome of our study. The absence of prior spinal radiographs precluded the identification of the precise time of occurrence of a documented fracture, resulting in the association between BMD and prevalent fractures being potentially limited by the time lag between the development of a fracture and BMD measurement. We could collect no reliable data on non-vertebral fractures, as these were poorly documented. However, previous studies report a generally low incidence of these fractures in end-stage liver disease.(2;5;6;8;19;29)
In conclusion, our finding of increased fracture risk independently of BMD in liver transplant recipients at time of screening for transplantation, adds to the accumulating body of evidence of the contributory role of bone quality rather than just bone quantity to fracture risk in patients with liver disease. This finding has significant clinical implications in the evaluation and management of prospective liver transplant recipients, as it suggests that spinal radiographs should be routinely performed in these patients to enable identification of vertebral fractures and thus of skeletal fragility.
Whether this pre-transplantation skeletal fragility persists, worsens or improves after liver transplantation, and whether bone fragility could be modulated by available bone-modifying agents to decrease or prevent skeletal morbidity after transplantation remains to be established by long-term studies specifically addressing the issue of skeletal health in liver transplant recipients.
